Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2013 1
2014 3
2015 2
2017 3
2018 3
2019 4
2020 5
2021 1
2022 4
2023 14
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).
Zhu HD, Li HL, Huang MS, Yang WZ, Yin GW, Zhong BY, Sun JH, Jin ZC, Chen JJ, Ge NJ, Ding WB, Li WH, Huang JH, Mu W, Gu SZ, Li JP, Zhao H, Wen SW, Lei YM, Song YS, Yuan CW, Wang WD, Huang M, Zhao W, Wu JB, Wang S, Zhu X, Han JJ, Ren WX, Lu ZM, Xing WG, Fan Y, Lin HL, Zhang ZS, Xu GH, Hu WH, Tu Q, Su HY, Zheng CS, Chen Y, Zhao XY, Fang ZT, Wang Q, Zhao JW, Xu AB, Xu J, Wu QH, Niu HZ, Wang J, Dai F, Feng DP, Li QD, Shi RS, Li JR, Yang G, Shi HB, Ji JS, Liu YE, Cai Z, Yang P, Zhao Y, Zhu XL, Lu LG, Teng GJ; CHANCE001 Investigators. Zhu HD, et al. Among authors: ding wb. Signal Transduct Target Ther. 2023 Feb 8;8(1):58. doi: 10.1038/s41392-022-01235-0. Signal Transduct Target Ther. 2023. PMID: 36750721 Free PMC article.
New Cyclic Diarylheptanoids from Platycarya strobilacea.
Ding WB, Zhao RY, Li GH, Liu BL, He HL, Qiu L, Xue J, Li YZ. Ding WB, et al. Molecules. 2020 Dec 20;25(24):6034. doi: 10.3390/molecules25246034. Molecules. 2020. PMID: 33419270 Free PMC article.
[Advances in clinical studies of chronic cough].
Lai KF, Huang LR, Chen YH, Ding WB, Xu TT, Xiang KH, Lin MT, Xu DT, Li YL, Chen ZY, Luo KZ, He W, Huang RX. Lai KF, et al. Among authors: ding wb. Zhonghua Jie He He Hu Xi Za Zhi. 2023 Oct 12;46(10):1022-1027. doi: 10.3760/cma.j.cn112147-20230109-00011. Zhonghua Jie He He Hu Xi Za Zhi. 2023. PMID: 37752047 Chinese.
Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study.
Jin ZC, Zhong BY, Chen JJ, Zhu HD, Sun JH, Yin GW, Ge NJ, Luo B, Ding WB, Li WH, Chen L, Wang YQ, Zhu XL, Yang WZ, Li HL, Teng GJ; CHANCE Investigators. Jin ZC, et al. Among authors: ding wb. Eur Radiol. 2023 Dec;33(12):8669-8681. doi: 10.1007/s00330-023-09754-2. Epub 2023 Jun 27. Eur Radiol. 2023. PMID: 37368105 Free PMC article.
miR-422a inhibits osteosarcoma proliferation by targeting BCL2L2 and KRAS.
Zhang H, He QY, Wang GC, Tong DK, Wang RK, Ding WB, Li C, Wei Q, Ding C, Liu PZ, Cui HC, Zhang X, Li D, Tang H, Ji F. Zhang H, et al. Among authors: ding wb. Biosci Rep. 2018 Mar 21;38(2):BSR20170339. doi: 10.1042/BSR20170339. Print 2018 Apr 27. Biosci Rep. 2018. PMID: 29358307 Free PMC article.
37 results